Multiple Myeloma Profile by FISH
Order Name
MULT MYEL
Test Number: 9115585
Revision Date 04/16/2024
Test Number: 9115585
Revision Date 04/16/2024
| Test Name | Methodology | LOINC Code |
|---|---|---|
|
Multiple Myeloma Profile by FISH
|
Fluorescence in Situ Hybridization |
| SPECIMEN REQUIREMENTS | ||||
|---|---|---|---|---|
| Specimen | Specimen Volume (min) | Specimen Type | Specimen Container | Transport Environment |
| Preferred | 5 mL (1 mL) | Bone Marrow | Sodium Heparin (Green Top, No-Gel) | Room Temperature |
| Alternate 1 | 5 mL (3 mL) | Whole Blood | Sodium Heparin (Green Top, No-Gel) | Room Temperature |
| Instructions | Send specimen ASAP, Keep at room temperature! (DO NOT FREEZE). Frozen samples will be rejected. | |||
| GENERAL INFORMATION | |
|---|---|
| Testing Schedule | Mon-Fri |
| Expected TAT | 3-5 Days |
| Clinical Use | Multiple Myeloma (MM) is characterized by the proliferation of malignant monoclonal plasma cells in the bone marrow. In most cases, there is low proliferation index of terminally different malignant plasma cells. As a result, conventional cytogenetic analysis frequently yields normal results. The most frequent abnormalities with prognostic association have been included in this panel [t(11;14)(CCND1;IGH), 13q14.3, 13q34, t(4;14)(FGFR3;IGH), 11q22.3(ATM), 17p13.1(TP53)]. Interphase FISH studies can enhance the detection rate and complement conventional cytogenetic techniques. |
| CPT Code(s) | 88377x5 |
| Lab Section | Reference Lab |